Back to results
US 10,945,967 B2Granted
Formulations of a transdermal patch for pain management
OwnerJae Wang. Songinventor
Life of this patent
Estimating the term…
Abstract
Various formulations (to be used in the form of a single-segment or multi-segment transdermal patch) of bioactive compounds for pain management are described/disclosed. The multi-segmented transdermal patch can include one or more compatible bioactive compounds in each segment. Furthermore, formulations may include silk fibroin and/or microemulsion/nanoemulsion of bioactive compounds and/or microencapsulation/nanoencapsulation of bioactive compounds.
Claims12
A transdermal patch for pain management,
- comprising:
- pharmaceutical formulation of
- (a) cannabidiol (CBD) or cannabidiol (CBD) pro-drug;
- (b) silk fibroin;
- (c) Boswellia serrata extract;
- and
- (d) a bioactive compound astaxanthin.
4 more elements
A transdermal patch for pain management,
- comprising:
- pharmaceutical formulation of
- (a) cannabidiol (CBD) or cannabidiol (CBD) pro-drug;
- (b) cannabichromene (CBC) or cannabichromene (CBC) pro-drug;
- (c) silk fibroin;
- (d) Boswellia serrata extract;
- and
- (e) a bioactive compound astaxanthin.
5 more elements
A transdermal patch for pain management,
- comprising:
- pharmaceutical formulation of
- (a) cannabidiol or cannabidiol pro-drug;
- (b) cannabichromene or cannabichromene pro-drug;
- (c) Boswellia serrata extract or capsaicin;
- (d) silk fibroin;
- and
- (e) a bioactive compound astaxanthin.
5 more elements
A transdermal patch for pain management,
- comprising:
- pharmaceutical formulation of
- (a) Boswellia serrata extract;
- (b) capsaicin;
- (c) silk fibroin, and
- (d) a bioactive compound astaxanthin.
3 more elements
Dependencies are inferred from the claim text.